The activation of PD-L1L2-SE is required for PD-L1 and PD-L2 expression on tumor cells and genetic deletion of PD-L1L2-SE leads to tumor cell loss of immune evasion and increased sensitivity to T-cell killing. Here, CD274 is linked to neoplasm.